What is the equivalent estrogen patch dose for a patient using 2 pumps of estrogen gel (estradiol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Estrogen Gel to Patch Conversion

Two pumps of estrogen gel (approximately 1.5-2 mg estradiol) converts to a 100 mcg/24-hour transdermal estradiol patch for equivalent systemic hormone replacement.

Dosing Equivalence

The conversion is based on standard formulation concentrations and delivery rates:

  • Estrogen gel: Most commercially available estradiol gels deliver approximately 0.75-1 mg estradiol per pump actuation 1, 2
  • Two pumps: This provides approximately 1.5-2 mg total estradiol dose 1
  • Patch equivalent: A 100 mcg/24-hour transdermal patch is the appropriate conversion for this gel dose 3, 4

Rationale for Conversion

The 100 mcg/24-hour patch falls within the recommended maintenance dose range of 100-200 mcg/day for adult women requiring hormone replacement therapy 3. This dosing achieves therapeutic estradiol levels while minimizing risks associated with supraphysiologic dosing.

For patients requiring lower doses, a 50 mcg/24-hour patch may be considered if symptoms are adequately controlled, as transdermal delivery at 50-100 μg daily is recommended for initial hormone replacement 4.

Application Guidelines

  • Patch frequency: Change patches either twice weekly or weekly depending on the specific brand formulation 3
  • Application sites: Apply to clean, dry, intact skin on the lower abdomen, upper buttocks, back, or upper arms 4
  • Endometrial protection: If the patient has an intact uterus, add progesterone (200 mg oral or vaginal micronized progesterone daily for 12-14 days every 28 days) for endometrial protection 3

Important Clinical Considerations

Transdermal delivery advantages: The patch formulation avoids first-pass hepatic metabolism, provides more stable hormone levels, and has a lower risk of venous thromboembolism compared to oral administration 4.

Monitoring: Evaluate treatment effect after 3-6 months and conduct annual clinical reviews to assess compliance and side effects 4. No routine laboratory monitoring is required unless specific symptoms develop 4.

References

Guideline

Transdermal Estrogen Patch Application Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dosing of Transdermal Estrogen and Cyclic Progesterone After Progesterone Therapy Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.